High Fat Liquid Shake for Lipid Disorder

KC
RD
Overseen ByRobert D Shamburek, M.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Background:

Obesity is known to lead to diseases such as diabetes and high cholesterol (or fats) in the blood (hyperlipidemia). But no one knows why. Researchers think that high levels of fat in the blood may block important nutrients, such as vitamin E, from reaching places they are needed in the body.

Objective:

To learn how high-fat meals affect levels of vitamin E in the blood.

Eligibility:

People aged 18 to 65 with high blood fat levels. Healthy volunteers are also needed.

Design:

Participants will have 3 or 4 clinic visits in 3 months. The last visit will require them to stay in the clinic for 2 nights.

Participants will be screened. They will have a physical exam and blood tests.

After this visit, all participants must stop taking any dietary supplements.

Those who use them must also stop taking any drugs to lower their blood sugar and blood fats. These participants will have an extra visit for blood tests after 60 days.

The next visit will include 2 imaging scans:

Magnetic resonance imaging (MRI) of the abdomen. This scan will check for fat in the liver.

Dual-energy X-ray absorptiometry (DEXA). This scan measures the levels of body fat.

On day 1 of the clinic stay, participants will have 2 set meals, with nothing but water after 10 pm.

On day 2, they will drink high-fat shakes at 8 am, noon, and 4 pm. They will have blood draws every hour for 17 hours, and then every 2 hours until 7 am. The blood will be taken from a tube inserted into a vein and left in place for the day.

On day 3, they will go home.

Who Is on the Research Team?

RD

Robert D Shamburek, M.D.

Principal Investigator

National Heart, Lung, and Blood Institute (NHLBI)

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65, both healthy and those with high blood fat levels. Participants must not have significant liver fat, major health issues, or recent large weight changes. They can't be pregnant, breastfeeding, current smokers, or unable to stop certain medications and supplements as required.

Inclusion Criteria

I have normal blood pressure and do not take medication for high blood pressure.
I am between 18 and 65 years old.
Cohort 1: Screening labs with baseline HbA1c <5.7%, baseline fasting triglyceride <150 mg/dL and LDL <100 mg/dL
See 9 more

Exclusion Criteria

Subjects with weight changes greater than 20% baseline body weight over past 3 months
I have at least 2% liver fat as shown on an abdominal MRI.
Subjects with hemoglobin <11 g/dL or hematocrit <33%
See 19 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Pre-Treatment Adjustment

Participants stop taking dietary supplements and drugs to lower blood sugar and blood fats

60 days
1 visit (in-person) for blood tests

Treatment

Participants consume three consecutive high-fat vitamin E-stripped meals and undergo various tests including MRI and DEXA scans

3 days
3-4 visits (in-person), including a 2-night clinic stay

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Trial Overview

The study tests how drinking high-fat shakes affects vitamin E levels in the blood. Participants will attend several clinic visits over three months and undergo scans and frequent blood draws after consuming the shakes to track nutrient changes.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Subjects with hyperlipidemiaExperimental Treatment1 Intervention
Group II: Healthy subjectsActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

National Heart, Lung, and Blood Institute (NHLBI)

Lead Sponsor

Trials
3,987
Recruited
47,860,000+